AstraZeneca Long Term Debt 2010-2024 | AZN

AstraZeneca long term debt for the quarter ending June 30, 2024 was $27.225B, a 11.9% increase year-over-year.

  • AstraZeneca long term debt for 2023 was $22.365B, a 2.61% decline from 2022.
  • AstraZeneca long term debt for 2022 was $22.965B, a 18.37% decline from 2021.
  • AstraZeneca long term debt for 2021 was $28.134B, a 60.72% increase from 2020.

AstraZeneca Long Term Debt 2010-2024 | AZN

  • AstraZeneca long term debt for 2023 was $22.365B, a 2.61% decline from 2022.
  • AstraZeneca long term debt for 2022 was $22.965B, a 18.37% decline from 2021.
  • AstraZeneca long term debt for 2021 was $28.134B, a 60.72% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$757B
Novo Nordisk (NVO)$483B
Johnson & Johnson (JNJ)$377.3B
AbbVie (ABBV)$354.3B
Merck (MRK)$255.9B
Novartis AG (NVS)$218.9B
Pfizer (PFE)$155.6B
Sanofi (SNY)$131.3B
Innoviva (INVA)$1.3B